MedPath

Post -Extubation Respiratory Failure

Not Applicable
Completed
Conditions
Respiratory Insufficiency
Interventions
Device: High flow nasal cannula
Registration Number
NCT04441736
Lead Sponsor
Cairo University
Brief Summary

comparing high flow nasal cannula , conventional oxygen tharapy and non invasive ventilation post-extubation period for patients mechanically ventilated due to respiratory failure regarding re-intubation rate, ICU outcome \& 28 days mortality

Detailed Description

patients with respiratory failure either type I or type II planned for extubation will be divided into 3 groups post extubation :

Group I: will receive high flow nasal cannula giving oxygen 60 litres / minute flow group II: will receive nasal cannula up to 10 litres / minute group III: will receive non invasive ventilation

Data of the patients will be collected for 28 days post-extubation and analysed

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • respiratory failure type I and Type II
Exclusion Criteria
  • Mechanical ventilation due to other cause such as disturbed conscious level or respiratory muscle weakness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High flow nasal cannulaHigh flow nasal cannulaA device of high flow nasal cannula giving 60 litres / min flow
Conventional oxygenHigh flow nasal cannulaNasal cannula giving oxygen up to 10 litres / minute
Non invasive ventilationHigh flow nasal cannulanon invasive ventilation with IPAP and EPAP
Primary Outcome Measures
NameTimeMethod
Number of participants with post extubation respiratory failure7 days

Number of participants with post extubation hypoxemia with or without hypercapnea

Secondary Outcome Measures
NameTimeMethod
Rate of ICU stay and mortality28 days

Duration of ICU stay and incidence of mortality

Trial Locations

Locations (1)

Faculty of Medicine

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath